Ohio’s top court ruled on Tuesday that pharmacy chain operators CVS Health (NYSE: CVS), Walmart (NYSE: WMT), and Walgreens (NASDAQ: […]
Pharmacies Prevail in Appeal of $650-Million Opioid Award in Ohio Read More »
Walgreens Boots Alliance (NASDAQ: WBA) is in talks to sell itself to private equity firm Sycamore Partners, according to a
Walgreens in Talks to Be Taken Private by Sycamore Partners, Source Says Read More »
BRUSSELS – On Friday, Novo Holdings gained unconditional EU antitrust approval for its $16.5 billion acquisition of U.S. contract drug
Novo Holdings Gains EU Antitrust Approval for $16.5 Billion Catalent Acquisition Read More »
China’s Zhifei will pay GSK (NYSE: GSK) about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK’s
GSK to Get Less from Zhifei Shingles Vaccine Deal; to Collaborate on RSV Read More »
Novartis (NYSE: NVS) failed to convince a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals’ proposed generic of Novartis’
US Appeals Court Rules Against Novartis in Heart Drug Patent Case Read More »
On Wednesday, Novavax (NASDAQ: NVAX), the U.S.-based vaccine maker, said it would sell its manufacturing facility in the Czech Republic
Novavax to Sell Czech Manufacturing Unit to Novo Nordisk for $200 Million Read More »
On Tuesday, the U.S. Centers for Disease Control and Prevention said that the E. coli outbreak linked to McDonald’s (NYSE:
E. coli Outbreak Tied to McDonald’s Quarter Pounders Has Ended, CDC Says Read More »
SHANGHAI – Sanofi (NASDAQ: SNY) plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production
Sanofi Announces its Biggest China Investment Deal Amid EU-China Trade Tensions Read More »
SHANGHAI – AstraZeneca’s (NASDAQ: AZN) blockbuster breast cancer drug Enhertu will be added to China’s state-run health insurance scheme from
China Adds AstraZeneca’s Breast Cancer Drug Enhertu to State Health Coverage Read More »
Copyright © 2024 abbonews.com
